NSG 6005
Midterm Pharmacology
Week 5 Exam
Actual Qs & Ans to Pass the Exam
THIS EXAM CONSIST OF
➢ Questions covering NSG 6005 Midterm week 5
➢ multiple-choice format (A, B, C, D) with Correct Answers
➢ Some questions feature brief "scenario" elements and rationales
➢ 100 Questions with 100% Correct Answers
,1.
Case Scenario: A nurse practitioner (NP) is incorporating the use of a smart device into a patient
encounter. The patient appears slightly uneasy as the NP types on the tablet while interviewing.
Which action(s) can the NP take to make the patient more comfortable with the smart device?
A. Explain what is being documented in real time
B. Maintain good eye contact while engaging the patient
C. Both A and B
D. Avoid using the smart device during the encounter
Correct Answer: C – Both A and B
Expert Rationale: Combining explanation and nonverbal engagement reduces patient anxiety
and builds trust. Patients may worry that attention to a device diminishes personalized care. By
maintaining eye contact while clarifying use, the NP fosters transparency and rapport.
2.
According to the U.S. Office of Minority Health, poor health outcomes among African
Americans are most attributed to:
A. Poor diet and lifestyle choices
B. Limited use of emergency care services
C. Genetic predispositions
D. Discrimination, cultural barriers, and lack of access to health care
Correct Answer: D – Discrimination, cultural barriers, and lack of access to health care
Expert Rationale: Social determinants of health, including systemic barriers, discrimination, and
limited access, significantly impact health disparities in minority populations, more than
individual lifestyle choices alone.
3.
Nurse practitioner prescriptive authority is regulated by:
A. Federal Drug Enforcement Administration (DEA)
B. Centers for Medicare and Medicaid Services (CMS)
, C. The State Board of Nursing for each state
D. U.S. Department of Health and Human Services (HHS)
Correct Answer: C – The State Board of Nursing for each state
Expert Rationale: Prescriptive authority is defined by each state’s nurse practice act. While
DEA issues numbers for controlled substances, scope and limitations are state-specific.
4.
Criteria for choosing an effective drug for a disorder include:
A. Asking the patient what drug they think would work best
B. Evidence-based guidelines, drug safety, and efficacy
C. Popularity of the drug in practice
D. Marketing and availability of samples
Correct Answer: B – Evidence-based guidelines, drug safety, and efficacy
Expert Rationale: Safe prescribing requires evidence-based practice, consideration of
pharmacodynamics, patient comorbidities, and safety profile—not patient preference or
marketing factors.
5.
Pharmacoeconomics is defined as:
A. The study of drug metabolism and elimination
B. The role of pharmaceutical companies in economics
C. The analysis of the costs and consequences of any healthcare-related treatment or service
D. The influence of insurance companies on drug availability
Correct Answer: C – The analysis of the costs and consequences of any healthcare-related
treatment or service
Expert Rationale: Pharmacoeconomics integrates cost-effectiveness, cost-benefit, and cost-
utility analyses, guiding resource allocation in patient care.
6.
Case Scenario: A patient requires frequent diagnostic tests to monitor therapeutic drug levels.
Which of the following is considered an indirect cost of these tests?
Midterm Pharmacology
Week 5 Exam
Actual Qs & Ans to Pass the Exam
THIS EXAM CONSIST OF
➢ Questions covering NSG 6005 Midterm week 5
➢ multiple-choice format (A, B, C, D) with Correct Answers
➢ Some questions feature brief "scenario" elements and rationales
➢ 100 Questions with 100% Correct Answers
,1.
Case Scenario: A nurse practitioner (NP) is incorporating the use of a smart device into a patient
encounter. The patient appears slightly uneasy as the NP types on the tablet while interviewing.
Which action(s) can the NP take to make the patient more comfortable with the smart device?
A. Explain what is being documented in real time
B. Maintain good eye contact while engaging the patient
C. Both A and B
D. Avoid using the smart device during the encounter
Correct Answer: C – Both A and B
Expert Rationale: Combining explanation and nonverbal engagement reduces patient anxiety
and builds trust. Patients may worry that attention to a device diminishes personalized care. By
maintaining eye contact while clarifying use, the NP fosters transparency and rapport.
2.
According to the U.S. Office of Minority Health, poor health outcomes among African
Americans are most attributed to:
A. Poor diet and lifestyle choices
B. Limited use of emergency care services
C. Genetic predispositions
D. Discrimination, cultural barriers, and lack of access to health care
Correct Answer: D – Discrimination, cultural barriers, and lack of access to health care
Expert Rationale: Social determinants of health, including systemic barriers, discrimination, and
limited access, significantly impact health disparities in minority populations, more than
individual lifestyle choices alone.
3.
Nurse practitioner prescriptive authority is regulated by:
A. Federal Drug Enforcement Administration (DEA)
B. Centers for Medicare and Medicaid Services (CMS)
, C. The State Board of Nursing for each state
D. U.S. Department of Health and Human Services (HHS)
Correct Answer: C – The State Board of Nursing for each state
Expert Rationale: Prescriptive authority is defined by each state’s nurse practice act. While
DEA issues numbers for controlled substances, scope and limitations are state-specific.
4.
Criteria for choosing an effective drug for a disorder include:
A. Asking the patient what drug they think would work best
B. Evidence-based guidelines, drug safety, and efficacy
C. Popularity of the drug in practice
D. Marketing and availability of samples
Correct Answer: B – Evidence-based guidelines, drug safety, and efficacy
Expert Rationale: Safe prescribing requires evidence-based practice, consideration of
pharmacodynamics, patient comorbidities, and safety profile—not patient preference or
marketing factors.
5.
Pharmacoeconomics is defined as:
A. The study of drug metabolism and elimination
B. The role of pharmaceutical companies in economics
C. The analysis of the costs and consequences of any healthcare-related treatment or service
D. The influence of insurance companies on drug availability
Correct Answer: C – The analysis of the costs and consequences of any healthcare-related
treatment or service
Expert Rationale: Pharmacoeconomics integrates cost-effectiveness, cost-benefit, and cost-
utility analyses, guiding resource allocation in patient care.
6.
Case Scenario: A patient requires frequent diagnostic tests to monitor therapeutic drug levels.
Which of the following is considered an indirect cost of these tests?
